<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ABB</journal-id><journal-title-group><journal-title>Advances in Bioscience and Biotechnology</journal-title></journal-title-group><issn pub-type="epub">2156-8456</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/abb.2015.64030</article-id><article-id pub-id-type="publisher-id">ABB-55935</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  A New Method for Cardiac Diseases Diagnosis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>idha</surname><given-names>Ben Salah</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tareq</surname><given-names>Alhadidi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sofienne</surname><given-names>Mansouri</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mounir</surname><given-names>Naouar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Higher Institute of Medical Technologies of Tunis, Laboratory of Biophysics, University of Tunis El Manar, Tunis, Tunisia</addr-line></aff><aff id="aff1"><addr-line>College of Applied Medical Sciences, Department of Medical Equipment Technology, Prince Sattam Bin Abdulaziz University, Al-Kharj, KSA</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>istmtrbs@yahoo.fr(IBS)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>04</month><year>2015</year></pub-date><volume>06</volume><issue>04</issue><fpage>311</fpage><lpage>319</lpage><history><date date-type="received"><day>22</day>	<month>March</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>20</month>	<year>April</year>	</date><date date-type="accepted"><day>24</day>	<month>April</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The objective of this work is to perform automatic diagnosis using a non invasive method which consists on the bioimpedance signal processing. Bioimpedance signal (BIS) represents the aorta impedance variation during the heart cycle activity. BIS is detected by mean of two electrodes located at the level of the ascendant aorta. Automatic diagnosis method consists on preparing, first, a data base with a set of cepstral parameters of different BIS according to normal case and different cardiac diseases. This data base is composed from n classes Yk corresponding to n diseases. The classification of anonymous individuals is based on the determination of Fisher distance between anonymous disease and class Yk using Fischer formula. Our method permits to calculate seven relevant cepstral parameters. The application of Fisher method has allowed us to perform the diagnosis of five anonymous cases. The major interest of this method is its especially useful for the exploration of cardiovascular system anomalies for emergency cases, children, elderly and pregnant women who can’t support surgical operations especially at the level of the heart.
 
</p></abstract><kwd-group><kwd>Signal Processing</kwd><kwd> Cepstral Parameters</kwd><kwd> Bioimpedance</kwd><kwd> Cardiac Diseases</kwd><kwd> Automatic Diagnosis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Several studies have been performed on medical signal processing with the aim of enriching the table in diagnosis of heart disease [<xref ref-type="bibr" rid="scirp.55935-ref1">1</xref>] -[<xref ref-type="bibr" rid="scirp.55935-ref4">4</xref>] . These signals include the ECG [<xref ref-type="bibr" rid="scirp.55935-ref1">1</xref>] signal, bioimpedance cardiovascular signal, doppler signal [<xref ref-type="bibr" rid="scirp.55935-ref4">4</xref>] -[<xref ref-type="bibr" rid="scirp.55935-ref6">6</xref>] , phonocardiogram signal… However, the majority of the work in this area remains targeted on a temporal signal processing allowing the computation of Cardiac output, cardiac frequency, systolic ejection duration, systolic ejection fraction [<xref ref-type="bibr" rid="scirp.55935-ref6">6</xref>] -[<xref ref-type="bibr" rid="scirp.55935-ref11">11</xref>] … The objective of this study is to design an automatic diagnosis of the cardio-vascular anomalies via a cepstral signal analysis. Our analysis shows the importance of the cepstral parameters for the classification of various cardiovascular diseases. In this work we proceed first to the description of the bioimpedance method, then we describe the signals cepstral approach [<xref ref-type="bibr" rid="scirp.55935-ref8">8</xref>] . The method of discriminant analysis [<xref ref-type="bibr" rid="scirp.55935-ref8">8</xref>] will enable us to confirm the relevance of the cepstral parameters in the cardiovascular diseases diagnosis. Cepstral parameters will be used then for the automatic diagnosis.</p></sec><sec id="s2"><title>2. Material and Method</title><sec id="s2_1"><title>2.1. Bioimpedance Method</title><p>The method used in this study consists of applying a low level rectangular current and high frequency (1 mA, 30 kHz), through a pair of electrodes placed respectively in the front and above the leading edge of the heart [<xref ref-type="bibr" rid="scirp.55935-ref12">12</xref>] -[<xref ref-type="bibr" rid="scirp.55935-ref15">15</xref>] . Another pair of electrodes, placed on the chest of the patient at the level of aorta 2 or 3 cm apart, permit perception of bioimpedance signal [BIS] representing impedance variation ∆Z of the explored thoracic region. <xref ref-type="fig" rid="fig1">Figure 1</xref>, shows the electrode configuration for the measurement of the bioimpedance signal.</p><p>The aim of this bioimpedance signal analysis is the diagnosis of cardiac diseases by means of cepstral processing of this signal using Fisher theory [<xref ref-type="bibr" rid="scirp.55935-ref16">16</xref>] -[<xref ref-type="bibr" rid="scirp.55935-ref18">18</xref>] .</p></sec><sec id="s2_2"><title>2.2. Cepstral Analysis</title><p>Cepstral method consists on considering that bioimpedance signal y(t) is the response of left ventricle aorta system to a cardiac excitation signal x(t) and the aorta pulsatile response h(t) (<xref ref-type="fig" rid="fig2">Figure 2</xref>):</p><p>Then:</p><disp-formula id="scirp.55935-formula1544"><label>(1)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x5.png"  xlink:type="simple"/></disp-formula><p>(Temporal convolution product)</p><p>Cepstral analysis consists on the determination of excitation signal x(t) and pulsatile response h(t), in order to describe, separately, anomalies, respectively, in heart and aorta. Computation is carried out at the minimum phase (Φ = 0).</p><p>Let:</p><disp-formula id="scirp.55935-formula1545"><label>(2)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x6.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.55935-formula1546"><label>(3)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x7.png"  xlink:type="simple"/></disp-formula><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Bioimpedance method</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/8-7301003x8.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Cepstral model</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/8-7301003x9.png"/></fig><p>where:</p><disp-formula id="scirp.55935-formula1547"><label>(4)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x10.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.55935-formula1548"><label>(5)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x11.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.55935-formula1549"><label>(6)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x12.png"  xlink:type="simple"/></disp-formula><p>Let:</p><disp-formula id="scirp.55935-formula1550"><label>(7)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x13.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.55935-formula1551"><label>(8)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x14.png"  xlink:type="simple"/></disp-formula><p>y<sub>1</sub>(t) is the Cepstre C1</p><p>where:</p><disp-formula id="scirp.55935-formula1552"><label>(9)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x15.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.55935-formula1553"><label>(10)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x16.png"  xlink:type="simple"/></disp-formula><p>Let:</p><disp-formula id="scirp.55935-formula1554"><label>(11)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x17.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.55935-formula1555"><label>(12)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x18.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.55935-formula1556"><label>(13)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x19.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.55935-formula1557"><label>(14)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x20.png"  xlink:type="simple"/></disp-formula><p>Let:</p><disp-formula id="scirp.55935-formula1558"><label>(15)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x21.png"  xlink:type="simple"/></disp-formula><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/8-7301003x22.png" xlink:type="simple"/></inline-formula>is the Cepstre C2</p><disp-formula id="scirp.55935-formula1559"><label>(16)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x23.png"  xlink:type="simple"/></disp-formula><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/8-7301003x24.png" xlink:type="simple"/></inline-formula>is the Cepstre C3.</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/8-7301003x25.png" xlink:type="simple"/></inline-formula>and <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/8-7301003x25.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/8-7301003x26.png" xlink:type="simple"/></inline-formula> are considered as the original signal provided, respectively, by heart and aorta.</p><p><xref ref-type="fig" rid="fig3">Figure 3</xref>, shows the different steps of the cepstral algorithm.</p></sec></sec><sec id="s3"><title>3. Result and Discussion</title><sec id="s3_1"><title>3.1. Temporal, Spectral and Cepstral Parameters</title><p>Early, a statistical study, using the discriminant method analysis, has been performed [<xref ref-type="bibr" rid="scirp.55935-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.55935-ref18">18</xref>] . This study consists to use 15 parameters: five temporal variables from bioimpedance signal and its derivative (A, C, O, X, S), 3 spectral parameters (r<sub>1</sub>, r<sub>2</sub>, r<sub>3</sub>) and seven cepstrals variables (U, M, N, F, I, G, LF) (<xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig5">Figure 5</xref>) and (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Our idea in this study is to use the seven cepstral parameters for the automatic diagnosis of the heart disease</p><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Cepstral analysis</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/8-7301003x27.png"/></fig><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Temporal parameters</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/8-7301003x28.png"/></fig><p>using Fisher’s test. Cesptres C2 and C3 permit to provide these seven relevant parameters: U, M, N, F, I, G, LF (<xref ref-type="table" rid="table2">Table 2</xref>).</p></sec><sec id="s3_2"><title>3.2. Discriminant Analysis Method</title><p>The principle of discriminant analysis is based on FISCHER theory and the criteria of “Step by Step”. The relevant plethysmographic parameters represent the set of parameters which allows having the maximum of matrix product T<sup>−1</sup> E. Where T is whole covariance matrix, E is the interclass covariance matrix. The classification of anonymous individuals is based on the use of the FISHER formula [<xref ref-type="bibr" rid="scirp.55935-ref16">16</xref>] :</p><disp-formula id="scirp.55935-formula1560"><label>(17)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x29.png"  xlink:type="simple"/></disp-formula><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/8-7301003x30.png" xlink:type="simple"/></inline-formula>is the Fisher distance between an anonymous individual and class Y<sub>k</sub>, a is the anonymous individual defined by cepstral parameters, y<sub>k</sub> is the average of Y<sub>k</sub> classes, T<sub>cov</sub> is whole covariance matrix.</p><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig5">Figure 5</xref></label><caption><title> C2 and C3 cepstral parameters</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/8-7301003x31.png"/></fig><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Temporal, spectral and cepstral parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="5"  >Temporal parameters</th><th align="center" valign="middle" >A</th><th align="center" valign="middle"  rowspan="4"  >Wave amplitude of the bioimpedance derivate signal</th></tr></thead><tr><td align="center" valign="middle" >C</td></tr><tr><td align="center" valign="middle" >O</td></tr><tr><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >S</td><td align="center" valign="middle" >Bioimpedance signal maximum amplitude</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Spectral parameters</td><td align="center" valign="middle" >r<sub>1</sub></td><td align="center" valign="middle"  rowspan="3"  >Spectral parameters <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/8-7301003x32.png" xlink:type="simple"/></inline-formula></td></tr><tr><td align="center" valign="middle" >r<sub>2</sub></td></tr><tr><td align="center" valign="middle" >r<sub>3</sub></td></tr><tr><td align="center" valign="middle"  rowspan="7"  >Cepstral parameters</td><td align="center" valign="middle" >U</td><td align="center" valign="middle"  rowspan="3"  >Cepstral parameters (cardiac excitation amplitude: cepstral C2)</td></tr><tr><td align="center" valign="middle" >M</td></tr><tr><td align="center" valign="middle" >N</td></tr><tr><td align="center" valign="middle" >F</td><td align="center" valign="middle"  rowspan="3"  >Cepstral parameters (impulsional response amplitude: cepstral C3)</td></tr><tr><td align="center" valign="middle" >I</td></tr><tr><td align="center" valign="middle" >G</td></tr><tr><td align="center" valign="middle" >LF</td><td align="center" valign="middle" >LF is the normalized width of wave F (aortic cepstral): =<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/8-7301003x33.png" xlink:type="simple"/></inline-formula>, T is the cardiac period and L is the width of the wave F.</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Cepstral parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Cepstral parameters</th><th align="center" valign="middle" >U</th><th align="center" valign="middle" >M</th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >F</th><th align="center" valign="middle" >I</th><th align="center" valign="middle" >G</th><th align="center" valign="middle" >LF</th></tr></thead><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >7</td></tr></tbody></table></table-wrap><p>Computed algorithms are expressed by a MAHAL 3 program [<xref ref-type="bibr" rid="scirp.55935-ref5">5</xref>] . The determination of the best discriminant parameters is carried out at each step from a basic sample (normal and cardiovascular diseases) with a dimension N calculated as follows with an error risk of 5% [<xref ref-type="bibr" rid="scirp.55935-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.55935-ref17">17</xref>] :</p><disp-formula id="scirp.55935-formula1561"><label>(18)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/8-7301003x34.png"  xlink:type="simple"/></disp-formula><p>P is the total of average cepstral parameters corresponding to 25 classes (<xref ref-type="table" rid="table3">Table 3</xref>)</p><p>Bioimpedance parameters, proposed for the discrimination between the classes, are in this study 7 cepstral parameters.</p><p>After testing the seven parameters during the first step, the program indicates the parameter number 7 which represents the normalized width LF of the aortic cepstral. Therefore, the parameter number 7 is the best discriminant plethismographic parameter. The best classified percentage of individual is then 64.29% (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>At steps number 2, 3 and 4, the program choose, respectively, parameters number 7, 5, 6 and 4 corresponding respectively to the parameters: LF, I, G and F. The classified percentage is then 86.01%. At step 5, the percentage of classification reaches 93.66% the parameters are 7, 5, 6, 4, and 3 corresponding to the parameters: LF, I, G, F and N. Finally at step number 6 and 7 the program choose parameters 2 and 1 corresponding to M and U respectively with the percentage 94.1% and 95.4%.</p><p>The total 7 independent parameters (<xref ref-type="table" rid="table4">Table 4</xref>), gives 99.4% degree of best classification. Therefore Bioimpedance cepstral parameters with best discrimination are: 7(Lf), 5(I), 6(G), 4(F), 3(N), 6(M), and 7(U).</p></sec><sec id="s3_3"><title>3.3. Automatic Diagnosis</title><p>Automatic diagnosis method consists on preparing, first, a data base with a set of the seven cepstral parameters</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Basic sample of average cepstral parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >F</th><th align="center" valign="middle" >LF</th><th align="center" valign="middle" >U</th><th align="center" valign="middle" >M</th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >I</th><th align="center" valign="middle" >G</th></tr></thead><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.49</td><td align="center" valign="middle" >0.19</td><td align="center" valign="middle" >0.21</td><td align="center" valign="middle" >0.17</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >0.32</td></tr><tr><td align="center" valign="middle" >M.D.</td><td align="center" valign="middle" >1.4</td><td align="center" valign="middle" >2.11</td><td align="center" valign="middle" >0.44</td><td align="center" valign="middle" >0.02</td><td align="center" valign="middle" >0.01</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >AO.I.</td><td align="center" valign="middle" >0.78</td><td align="center" valign="middle" >0.54</td><td align="center" valign="middle" >0.18</td><td align="center" valign="middle" >0.20</td><td align="center" valign="middle" >0.17</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >0.49</td></tr><tr><td align="center" valign="middle" >AO.S.</td><td align="center" valign="middle" >0.17</td><td align="center" valign="middle" >0.88</td><td align="center" valign="middle" >0.17</td><td align="center" valign="middle" >0.21</td><td align="center" valign="middle" >0.17</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >0.30</td></tr><tr><td align="center" valign="middle" >AO.D.</td><td align="center" valign="middle" >1.16</td><td align="center" valign="middle" >0.89</td><td align="center" valign="middle" >0.19</td><td align="center" valign="middle" >0.21</td><td align="center" valign="middle" >0.16</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.30</td></tr><tr><td align="center" valign="middle" >M.I.</td><td align="center" valign="middle" >1.4</td><td align="center" valign="middle" >1.57</td><td align="center" valign="middle" >0.15</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.30</td></tr><tr><td align="center" valign="middle" >M.S.</td><td align="center" valign="middle" >1.11</td><td align="center" valign="middle" >0.79</td><td align="center" valign="middle" >0.10</td><td align="center" valign="middle" >0.03</td><td align="center" valign="middle" >0.02</td><td align="center" valign="middle" >0.19</td><td align="center" valign="middle" >0.11</td></tr><tr><td align="center" valign="middle" >M.D.++</td><td align="center" valign="middle" >1.44</td><td align="center" valign="middle" >2.21</td><td align="center" valign="middle" >0.54</td><td align="center" valign="middle" >0.12</td><td align="center" valign="middle" >0.11</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >0.1</td></tr><tr><td align="center" valign="middle" >AO.I.++</td><td align="center" valign="middle" >0.88</td><td align="center" valign="middle" >0.64</td><td align="center" valign="middle" >0.28</td><td align="center" valign="middle" >0.30</td><td align="center" valign="middle" >0.27</td><td align="center" valign="middle" >015</td><td align="center" valign="middle" >0.59</td></tr><tr><td align="center" valign="middle" >AO.S.++</td><td align="center" valign="middle" >0.27</td><td align="center" valign="middle" >0.98</td><td align="center" valign="middle" >0.27</td><td align="center" valign="middle" >0.31</td><td align="center" valign="middle" >0.27</td><td align="center" valign="middle" >0.15</td><td align="center" valign="middle" >0.40</td></tr><tr><td align="center" valign="middle" >AO.D.++</td><td align="center" valign="middle" >1.26</td><td align="center" valign="middle" >0.99</td><td align="center" valign="middle" >0.29</td><td align="center" valign="middle" >0.31</td><td align="center" valign="middle" >0.26</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >0.40</td></tr><tr><td align="center" valign="middle" >M.I.++</td><td align="center" valign="middle" >1.5</td><td align="center" valign="middle" >1.67</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.15</td><td align="center" valign="middle" >0.15</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >0.40</td></tr><tr><td align="center" valign="middle" >M.S.++</td><td align="center" valign="middle" >1.21</td><td align="center" valign="middle" >0.89</td><td align="center" valign="middle" >0.20</td><td align="center" valign="middle" >0.13</td><td align="center" valign="middle" >0.12</td><td align="center" valign="middle" >0.29</td><td align="center" valign="middle" >0.21</td></tr><tr><td align="center" valign="middle" >M.D.+++</td><td align="center" valign="middle" >1.60</td><td align="center" valign="middle" >2.31</td><td align="center" valign="middle" >0.64</td><td align="center" valign="middle" >0.22</td><td align="center" valign="middle" >0.21</td><td align="center" valign="middle" >0.2</td><td align="center" valign="middle" >0.2</td></tr><tr><td align="center" valign="middle" >AO.I.+++</td><td align="center" valign="middle" >0.98</td><td align="center" valign="middle" >0.74</td><td align="center" valign="middle" >0.38</td><td align="center" valign="middle" >0.40</td><td align="center" valign="middle" >0.37</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.69</td></tr><tr><td align="center" valign="middle" >AO.S.+++</td><td align="center" valign="middle" >0.37</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >0.37</td><td align="center" valign="middle" >0.41</td><td align="center" valign="middle" >0.37</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.50</td></tr><tr><td align="center" valign="middle" >AO.D.+++</td><td align="center" valign="middle" >1.36</td><td align="center" valign="middle" >0.11</td><td align="center" valign="middle" >0.39</td><td align="center" valign="middle" >0.41</td><td align="center" valign="middle" >0.36</td><td align="center" valign="middle" >0.2</td><td align="center" valign="middle" >0.50</td></tr><tr><td align="center" valign="middle" >M.I.+++</td><td align="center" valign="middle" >1.6</td><td align="center" valign="middle" >1.77</td><td align="center" valign="middle" >0.35</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.2</td><td align="center" valign="middle" >0.50</td></tr><tr><td align="center" valign="middle" >M.S.+++</td><td align="center" valign="middle" >1.31</td><td align="center" valign="middle" >0.99</td><td align="center" valign="middle" >0.30</td><td align="center" valign="middle" >0.23</td><td align="center" valign="middle" >0.22</td><td align="center" valign="middle" >0.39</td><td align="center" valign="middle" >0.31</td></tr><tr><td align="center" valign="middle" >P.S.</td><td align="center" valign="middle" >1.4</td><td align="center" valign="middle" >2.11</td><td align="center" valign="middle" >0.44</td><td align="center" valign="middle" >0.02</td><td align="center" valign="middle" >0.01</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >PS++</td><td align="center" valign="middle" >0.78</td><td align="center" valign="middle" >0.54</td><td align="center" valign="middle" >0.18</td><td align="center" valign="middle" >0.20</td><td align="center" valign="middle" >0.17</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >0.49</td></tr><tr><td align="center" valign="middle" >P.S+++</td><td align="center" valign="middle" >0.12</td><td align="center" valign="middle" >0.88</td><td align="center" valign="middle" >0.17</td><td align="center" valign="middle" >0.21</td><td align="center" valign="middle" >0.17</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >0.30</td></tr><tr><td align="center" valign="middle" >IVC</td><td align="center" valign="middle" >1.16</td><td align="center" valign="middle" >0.89</td><td align="center" valign="middle" >0.19</td><td align="center" valign="middle" >0.21</td><td align="center" valign="middle" >0.16</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.30</td></tr><tr><td align="center" valign="middle" >IAC</td><td align="center" valign="middle" >1.4</td><td align="center" valign="middle" >1.57</td><td align="center" valign="middle" >0.15</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.30</td></tr><tr><td align="center" valign="middle" >CMP.</td><td align="center" valign="middle" >1.11</td><td align="center" valign="middle" >0.79</td><td align="center" valign="middle" >0.10</td><td align="center" valign="middle" >0.03</td><td align="center" valign="middle" >0.02</td><td align="center" valign="middle" >0.19</td><td align="center" valign="middle" >0.11</td></tr></tbody></table></table-wrap><p>(AO.I: aortic insufficiency; AO.S: aortic stenosis; AO.D: aortic diseases; M.I: Mitral Insufficiency; M.S: Mitral stenosis; M.D: Mitral diseases; PS: pulmonary stenosis; IVC: Inter-ventricle communication; IAC: inter-atrium communication; CMP: Cardio-myopathie).</p><p>of different bioimpedance signal according to different cardiac diseases and the formula (18). This data base is composed from n classes Yk corresponding to 25 cases (normal and cardiac disease).</p><p>The classification of anonymous individuals is based on the use of FISHER formula (8). Minimum dm distance, between a and the Yk, classes provides the kind of cardiac disease. Investigation has concerned a data base of 25 kinds of signal: one normal and 24 pathological cases (<xref ref-type="table" rid="table3">Table 3</xref>). The number of cross indicates the severity of the disease.</p><p>Three cases of anonymous signals are used (a1: AO.S+), (a2: M.S++) and (a3: M.S+++). The diagnosis of these three anonymous cases is confirmed by Echo-Doppler method. <xref ref-type="table" rid="table5">Table 5</xref> shows affectation of these cases.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Step by step analysis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Steps</th><th align="center" valign="middle" >Parameters</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >64.29%</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >7, 5</td><td align="center" valign="middle" >81.71%</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >7, 5, 6</td><td align="center" valign="middle" >83.52%</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >7, 5, 6, 4</td><td align="center" valign="middle" >86.01%</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >7, 8, 6, 4, 3</td><td align="center" valign="middle" >93.66%</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >7, 8, 6, 4, 3, 2</td><td align="center" valign="middle" >94.10%</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >7, 8, 6, 4, 3, 2, 1</td><td align="center" valign="middle" >95.40%</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Anonymous individual affection</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >25 classes</th><th align="center" valign="middle" >d(a1)</th><th align="center" valign="middle" >d(a2)</th><th align="center" valign="middle" >d(a3)</th></tr></thead><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >99.70</td><td align="center" valign="middle" >99.50</td></tr><tr><td align="center" valign="middle" >M.D.+</td><td align="center" valign="middle" >55.30</td><td align="center" valign="middle" >66.23</td><td align="center" valign="middle" >62.39</td></tr><tr><td align="center" valign="middle" >AO.I.+</td><td align="center" valign="middle" >22.23</td><td align="center" valign="middle" >77.32</td><td align="center" valign="middle" >88.36</td></tr><tr><td align="center" valign="middle" >AO.S.+</td><td align="center" valign="middle" >0.10</td><td align="center" valign="middle" >55.11</td><td align="center" valign="middle" >55.22</td></tr><tr><td align="center" valign="middle" >AO.D.+</td><td align="center" valign="middle" >12.22</td><td align="center" valign="middle" >53.78</td><td align="center" valign="middle" >45.36</td></tr><tr><td align="center" valign="middle" >M.I.+</td><td align="center" valign="middle" >55.88</td><td align="center" valign="middle" >26.33</td><td align="center" valign="middle" >12.66</td></tr><tr><td align="center" valign="middle" >M.S.+</td><td align="center" valign="middle" >77.23</td><td align="center" valign="middle" >2.22</td><td align="center" valign="middle" >1.33</td></tr><tr><td align="center" valign="middle" >M.D.++</td><td align="center" valign="middle" >88.22</td><td align="center" valign="middle" >44.23</td><td align="center" valign="middle" >23.78</td></tr><tr><td align="center" valign="middle" >AO.I.++</td><td align="center" valign="middle" >55.99</td><td align="center" valign="middle" >88.66</td><td align="center" valign="middle" >88.77</td></tr><tr><td align="center" valign="middle" >AO.S.++</td><td align="center" valign="middle" >2.33</td><td align="center" valign="middle" >55.88</td><td align="center" valign="middle" >77.11</td></tr><tr><td align="center" valign="middle" >AO.D.++</td><td align="center" valign="middle" >4.66</td><td align="center" valign="middle" >69.58</td><td align="center" valign="middle" >88.55</td></tr><tr><td align="center" valign="middle" >M.I.++</td><td align="center" valign="middle" >54.99</td><td align="center" valign="middle" >22.30</td><td align="center" valign="middle" >22.99</td></tr><tr><td align="center" valign="middle" >M.S.++</td><td align="center" valign="middle" >55.21</td><td align="center" valign="middle" >0.10</td><td align="center" valign="middle" >1.59</td></tr><tr><td align="center" valign="middle" >M.D.+++</td><td align="center" valign="middle" >88.22</td><td align="center" valign="middle" >3.44</td><td align="center" valign="middle" >6.33</td></tr><tr><td align="center" valign="middle" >AO.I.+++</td><td align="center" valign="middle" >5.99</td><td align="center" valign="middle" >88.66</td><td align="center" valign="middle" >66.77</td></tr><tr><td align="center" valign="middle" >AO.S.+++</td><td align="center" valign="middle" >3..66</td><td align="center" valign="middle" >55.66</td><td align="center" valign="middle" >44.45</td></tr><tr><td align="center" valign="middle" >AO.D.+++</td><td align="center" valign="middle" >5.55</td><td align="center" valign="middle" >55.77</td><td align="center" valign="middle" >64.23</td></tr><tr><td align="center" valign="middle" >M.I.+++</td><td align="center" valign="middle" >45.66</td><td align="center" valign="middle" >28.99</td><td align="center" valign="middle" >34.54</td></tr><tr><td align="center" valign="middle" >M.S.+++</td><td align="center" valign="middle" >55.22</td><td align="center" valign="middle" >2.99</td><td align="center" valign="middle" >0.02</td></tr><tr><td align="center" valign="middle" >P.S.</td><td align="center" valign="middle" >77.32</td><td align="center" valign="middle" >54.88</td><td align="center" valign="middle" >88.52</td></tr><tr><td align="center" valign="middle" >PS++</td><td align="center" valign="middle" >75.41</td><td align="center" valign="middle" >55.66</td><td align="center" valign="middle" >66.25</td></tr><tr><td align="center" valign="middle" >P.S+++</td><td align="center" valign="middle" >88.23</td><td align="center" valign="middle" >74.36</td><td align="center" valign="middle" >67.99</td></tr><tr><td align="center" valign="middle" >IVC</td><td align="center" valign="middle" >90.23</td><td align="center" valign="middle" >95.24</td><td align="center" valign="middle" >89.99</td></tr><tr><td align="center" valign="middle" >IAC</td><td align="center" valign="middle" >79.99</td><td align="center" valign="middle" >92.32</td><td align="center" valign="middle" >88.99</td></tr><tr><td align="center" valign="middle" >CMP</td><td align="center" valign="middle" >55.58</td><td align="center" valign="middle" >88.45</td><td align="center" valign="middle" >96.33</td></tr></tbody></table></table-wrap></sec><sec id="s3_4"><title>3.4. Discussion</title><p>From <xref ref-type="table" rid="table4">Table 4</xref>, it can be noted that the parameter 7 (LF) has the best discriminating power with a percentage of well class 64.29%, which confirms the results found by Ben Salah et al. [<xref ref-type="bibr" rid="scirp.55935-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.55935-ref17">17</xref>] .</p><p>At step 7 the percentage of well class reaches 95.40%. This result is slightly better than the one we found in previous work using 15 bioimpedance parameters: 94.64% of percentage of correctly classified.</p><p>The results found in this work indicate that the seven cepstral parameters defined above are sufficient to perform the automatic diagnosis of the cardiovascular system abnormalities.</p><p>The effectiveness of the cepstral parameters classification is confirmed by the exact allocation of 3 anonymous individuals. Indeed our results demonstrate that patients a1, a2, a3 have been allocated respectively to the previous classes: AO.S+ (d = 0.1), M.S.++ (d = 0.1), and D.M.+++ (d = 0.02).</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>Automatic quantification of cardiac diseases has been carried out using discriminant analysis method based on the processing of bioimpedance signal. The discrimination uses analysis of seven cepstral parameters. Classifi- cation has been performed using e fundamental data base composed of 25 classes (one normal and 24 cases of diseases). “Step by step” method gives an excellent degree of discrimination 954%. The intelligent method performed in this study permits to confirm the classification of three anonymous patients. Quantification results obtained by the bioimpedance signals analysis are confirmed by those obtained with Echo-Doppler method. Researches are actually orientated for the investigation of peripheral cardiovascular system with the use of hemodynamic bioimpedance and ECG parameters.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.55935-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Yan, J.Y., Lu, Y., Liu, J. and Wu, X.Y. (2010) Intelligent Diagnosis of Cardiovascular Diseases Utilizing ECG Signals. International Journal of Information Acquisition, 07, 81. http://dx.doi.org/10.1142/S0219878910002087</mixed-citation></ref><ref id="scirp.55935-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kumaravel, N., Sridhar, K.S. and Nithiyanandam, N. (1996) Automatic Diagnosis of Heart Diseases Using Neural Network. Biomedical Engineering Conference, Dayton, 29-31 March 1996, 319-322. http://dx.doi.org/10.1109/SBEC.1996.493214</mixed-citation></ref><ref id="scirp.55935-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Hong, B., Kai, J., Ren, Y., Han, J., Zou, Z., Ahn, C.H. and Kang, K.A. (2008) Highly Sensitive Rapid, Reliable, and Automatic Cardiovascular Disease Diagnosis with Nanoparticle Fluorescence Enhancer and Mems. Advances in Experimental Medicine and Biology, 614, 265-273. http://dx.doi.org/10.1007/978-0-387-74911-2_30</mixed-citation></ref><ref id="scirp.55935-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Scherhag, A.W., et al. (2013) Continuous Measurement of Hemodynamic Alterations during Pharmacologic Cardiovascular Stress Using Automated Impedance Cardiography. The Journal of Clinical Pharmacology, 37, 21S-28S.</mixed-citation></ref><ref id="scirp.55935-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Fortin, J., et al. (2006) Non-Invasive Beat-To-Beat Cardiac Output Monitoring by an Improved Method of Transthoracic Bioimpedance Measurement. Computers in Biology and Medicine, 36, 1185-1203. http://dx.doi.org/10.1016/j.compbiomed.2005.06.001</mixed-citation></ref><ref id="scirp.55935-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Kubicek, W.G., Karnegis, J.N., Patterson, R.P., Witsoe, D.A. and Mattson, R.H. (1966) Development and Evaluation of an Impedance Cardiac Output System. Aerospace Medicine, 37, 1208-1212.</mixed-citation></ref><ref id="scirp.55935-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Bizouarn, P., Blanloeil, Y. and De La Coussaye, J.E. (1996) Conférences d’actualisation “Méthodes de mesure du débit cardiaque en réanimation”. Elsevier, Paris, et Société Fran&amp;ccedilaise d’Anesthésie et de Réanimation (SFAR), 377-398.</mixed-citation></ref><ref id="scirp.55935-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ben Salah, R. (1988) Pléthysmographie électrique thoracique localisée. Application à la détermination des paramètres cardiovasculaires et au diagnostic des cardiopathies. Ph.D. Faculté des sciences de Tunis.</mixed-citation></ref><ref id="scirp.55935-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Chemam, M.N. (1983) Analyse automatique des signaux pléthysmographiques. Application à la mesure du débit sanguin et à la reconnaissance des cardiopathies. Ph.D. Dissetation, ENIT, Tunis.</mixed-citation></ref><ref id="scirp.55935-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Collete, M., Leftheriotis, G. and Humeau, A. (2009) Modeling and Interpretation of the Bioelectrical Impedance Signal for the Determination of the Local Arterial Stiffness. Medical Physics, 36, 4340-4348. http://dx.doi.org/10.1118/1.3213084</mixed-citation></ref><ref id="scirp.55935-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ivorra, A. (2002) Bioimpédance Monitoring for Physicians: An Overview. Centre Nacional de Microelectrònica, Barcelona, Spain.</mixed-citation></ref><ref id="scirp.55935-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Kubicek, W.G., Patterson, R.P. and Witsoe, D.A. (1970) Impedance Cardiography as a Non Invasive Method of Monitoring Cardiac Function and Other Parameters of the Cardiovascular System. Annals of the N. Y. Academy of Sciences, 170, 724-732. http://dx.doi.org/10.1111/j.1749-6632.1970.tb17735.x</mixed-citation></ref><ref id="scirp.55935-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Mansouri, S., Mahjoubi, H. and Ben Salah, R. (2010) Determination of Instantaneous Arterial Blood Pressure from Bio-Impedance Signal. Journal of Biophysics and Structural Biology, 2, 009-015.</mixed-citation></ref><ref id="scirp.55935-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Mansouri, S., Mahjoubi, H. and Ben Salah, R. (2009) FPGA-Based Derivative Module for Bioimpedance Signal. International Journal of Computer Science and Network Security, 9, 16-20.</mixed-citation></ref><ref id="scirp.55935-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Mansouri, S. (2011) Conception d’un système de détermination non invasive des paramètres biorhéologiques cardiovasculaire par la méthode de bioimpédance périphérique. Ph.D. Faculté des sciences de Tunis.</mixed-citation></ref><ref id="scirp.55935-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Romeder, J.M. (1973) Méthode et programme d’analyse discriminante, Dunod.</mixed-citation></ref><ref id="scirp.55935-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Ben Salah, R., et al. (1988) Temporal, Spectral and Cepstral Analysis of Plethysmographic Signal. Application to Automatic Diagnosis of Cardiac Diseases. Signal Processing IV. Thories and Applications. Elsevier Science Publishers B. V., North Holland.</mixed-citation></ref><ref id="scirp.55935-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ben Salah, R. and Mansouri, S. (2008) Automatical Diagnosis of Cardiac Diseases by Cepstral Processing of the Bioimpédance Signal. 3rd IEEE International Conference on information and Communication Technologies: From Theory to Applications. Damascuc, 7-11 April 2008, 7-11.</mixed-citation></ref></ref-list></back></article>